TY - THES A1 - König, Jana T1 - Synthese und Charakterisierung von 3d-4f-Komplexen und deren Vorläufer mit 1,2-Dithiooxalat als Ligand Y1 - 2016 ER - TY - JOUR A1 - Träger, Juliane A1 - König, Jana A1 - Städtke, Anja A1 - Holdt, Hans-Jürgen T1 - Development of a solvent extraction system with 1,2-bis(2-methoxyethylthio) benzene for the selective separation of palladium(II) from secondary raw materials JF - Hydrometallurgy : an international journal devoted to all aspects of the aqueous processing of metals N2 - The chelating dithioether 1,2-bis(2-methoxyethylthio)benzene. a novel solvent extractant for Pd(II), is aimed to be utilised in the selective recovery of palladium from spent automotive catalysts. For that, the extraction system has been further customised, including the choice of an appropriate diluent (1,2-dichlorobenzene) as well as an effective stripping agent (0.5 M thiourea in 0.1 M HCl), which both have been selected from a number of potential agents. It is shown in batch experiments that the selectivity for Pd(II) is maintained when the organic phase (10(-2) M 1,2-bis(2-methoxyethylthio)benzene in 1,2-dichlorobenzene) is used several times to extract an oxidising leach solution. According to the McCabe-Thiele plot two theoretical stages are needed to extract more than 98% of the Pd(II) contained in that solution. The calculation of the thermodynamic quantities Delta H degrees. Delta S degrees and Delta G degrees reveals that the reaction is entropy driven - the temperature has only a slight influence on the extraction yield. It is demonstrated that the mono-oxidised extractant has a catalytic effect on the extraction kinetics when the aqueous phase contains highly concentrated hydrochloric acid. HPLC measurements prove the presence of small quantities of 1-(2-methoxyethylsulfinyl)-2-(2-methoxyethylthio) benzene in the organic phase. KW - Solvent extraction KW - Palladium KW - S ligands KW - Extraction system development KW - Stripping Y1 - 2012 U6 - https://doi.org/10.1016/j.hydromet.2012.07.002 SN - 0304-386X SN - 1879-1158 VL - 127 IS - 5 SP - 30 EP - 38 PB - Elsevier CY - Amsterdam ER - TY - GEN A1 - König, Jana A1 - Kelling, Alexandra A1 - Schilde, Uwe A1 - Strauch, Peter T1 - [µ2-O,O′,Oʺ,Oʺ′-Bis(1,2-dithiooxalato-S,S′)nickel(II)]bis[-O,O′-bis(1,2-dithiooxalato-S,S′)-nickel(II)pentaquaholmium(III)]hydrate, [Ho2Ni3(dto)6(H2O)10] N2 - Planar bis(1,2-dithiooxalato)nickelate(II), [Ni(dto)]2− reacts in aqueous solutions with lanthanide ions (Ln3+) to form pentanuclear, hetero-bimetallic complexes of the general composition [{Ln(H2O)n}2{Ni(dto)2}3]·xH2O. (n = 4 or 5; x = 9–12). The complex [{Ho(H2O)5}2{Ni(dto)2}3]·10H2O, Ho2Ni3, was synthesized and characterized by single crystal X-ray structure analysis and powder diffraction. The Ho2Ni3 complex crystallizes as monoclinic crystals in the space group P21/c. The channels and cavities, appearing in the crystal packing of the complex molecules, are occupied by a varying amount of non-coordinated water molecules. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 360 KW - lanthanides KW - holmium(III) KW - 1,2-dithiooxalate KW - crystal structure KW - nickel(II) Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-400598 ER - TY - GEN A1 - Raupbach, Jana A1 - Ott, Christiane A1 - König, Jeannette A1 - Grune, Tilman T1 - Proteasomal degradation of glycated proteins depends on substrate unfolding BT - preferred degradation of moderately modified myoglobin T2 - Postprints der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe N2 - The Maillard reaction generates protein modifications which can accumulate during hyperglycemia or aging and may have inflammatory consequences. The proteasome is one of the major intracellular systems involved in the proteolytic degradation of modified proteins but its role in the degradation of glycated proteins is scarcely studied. In this study, chemical and structural changes of glycated myoglobin were analyzed and its degradation by 20S proteasome was studied. Myoglobin was incubated with physiological (5-10 mM), moderate (50-100 mM) and severe levels (300 mM) of glucose or methylglyoxal (MGO, 50 mM). Glycation increased myoglobin's fluorescence and surface hydrophobicity. Severe glycation generated crosslinked proteins as shown by gel electrophoresis. The concentration of advanced glycation endproducts (AGEs) N-epsilon-carboxymethyl lysine (CML), N-epsilon-carboxyethyl lysine (CEL), methylglyoxal-derived hydroimidazolone-1 (MG-H1), pentosidine and pyrraline was analyzed after enzymatic hydrolysis followed by UPLC-MS/MS. Higher concentrations of glucose increased all analyzed AGEs and incubation with MGO led to a pronounced increase of CEL and MG-H1. The binding of the heme group to apo-myoglobin was decreased with increasing glycation indicating the loss of tertiary protein structure. Proteasomal degradation of modified myoglobin compared to native myoglobin depends on the degree of glycation: physiological conditions decreased proteasomal degradation whereas moderate glycation increased degradation. Severe glycation again decreased proteolytic cleavage which might be due to crosslinking of protein monomers. The activity of the proteasomal subunit beta 5 is influenced by the presence of glycated myoglobin. In conclusion, the role of the proteasome in the degradation of glycated proteins is highly dependent on the level of glycation and consequent protein unfolding. KW - glycation KW - myoglobin KW - heme KW - advanced glycation endproducts KW - 20S proteasome Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-527570 SN - 1866-8372 SP - 516 EP - 524 ER - TY - JOUR A1 - Raupbach, Jana A1 - Ott, Christiane A1 - König, Jeannette A1 - Grune, Tilman T1 - Proteasomal degradation of glycated proteins depends on substrate unfolding: Preferred degradation of moderately modified myoglobin JF - Free radical biology and medicine : the official journal of the Oxygen Society, a constituent member of the International Society for Free Radical Research N2 - The Maillard reaction generates protein modifications which can accumulate during hyperglycemia or aging and may have inflammatory consequences. The proteasome is one of the major intracellular systems involved in the proteolytic degradation of modified proteins but its role in the degradation of glycated proteins is scarcely studied. In this study, chemical and structural changes of glycated myoglobin were analyzed and its degradation by 20S proteasome was studied. Myoglobin was incubated with physiological (5-10 mM), moderate (50-100 mM) and severe levels (300 mM) of glucose or methylglyoxal (MGO, 50 mM). Glycation increased myoglobin's fluorescence and surface hydrophobicity. Severe glycation generated crosslinked proteins as shown by gel electrophoresis. The concentration of advanced glycation endproducts (AGEs) N-epsilon-carboxymethyl lysine (CML), N-epsilon-carboxyethyl lysine (CEL), methylglyoxal-derived hydroimidazolone-1 (MG-H1), pentosidine and pyrraline was analyzed after enzymatic hydrolysis followed by UPLC-MS/MS. Higher concentrations of glucose increased all analyzed AGEs and incubation with MGO led to a pronounced increase of CEL and MG-H1. The binding of the heme group to apo-myoglobin was decreased with increasing glycation indicating the loss of tertiary protein structure. Proteasomal degradation of modified myoglobin compared to native myoglobin depends on the degree of glycation: physiological conditions decreased proteasomal degradation whereas moderate glycation increased degradation. Severe glycation again decreased proteolytic cleavage which might be due to crosslinking of protein monomers. The activity of the proteasomal subunit beta 5 is influenced by the presence of glycated myoglobin. In conclusion, the role of the proteasome in the degradation of glycated proteins is highly dependent on the level of glycation and consequent protein unfolding. KW - Glycation KW - Myoglobin KW - Heme KW - Advanced glycation endproducts KW - 20S KW - proteasome Y1 - 2020 U6 - https://doi.org/10.1016/j.freeradbiomed.2019.11.024 SN - 0891-5849 SN - 1873-4596 VL - 152 SP - 516 EP - 524 PB - Elsevier CY - New York ER -